Yuanyuan Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yuanyuan Duan has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Jingmao You
Institute of Chinese Herbal Medicines, Hubei Academy of Agricultural Sciences, Enshi 445000, China
4 shared publications - Haitao Niu
Key Laboratory of Viral Pathogenesis and Infection Prevention and Control (Jinan University), Ministry of Education, School of Medicine, Jinan University, Guangzhou, China
3 shared publications Jiajia Yuan
Key Laboratory of Viral Pathogenesis & Infection Prevention and Control (Jinan University), Ministry of Education, Guangzhou Key Laboratory for Germ Free Animals and Microbiota Application, School of Medicine, Jinan University, Guangzhou, China
3 shared publicationsShan Jiang
School of Nursing, Guangzhou University of Chinese Medicine, Guangzhou, China
3 shared publicationsFanfan Wang
Institute of Chinese Herbal Medicines, Hubei Academy of Agricultural Sciences, Enshi, 445000, China
2 shared publications- Fanfan Wang
Key Laboratory of Biology and Cultivation of Chinese Herbal Medicines, Ministry of Agriculture and Rural Affairs, Institute of Chinese Herbal Medicines, Hubei Academy of Agricultural Sciences, Enshi 445000, China
2 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Paeoniflorin Modulates Gut Microbiota–Derived Lysophospholipids to Restore Th17/Treg Homeostasis in Systemic Lupus Erythematosus
- 20 August 2026
- Published by Springer Nature in Inflammation
- Vol. 49 (1)
Open AccessPaeoniflorin Modulates Gut Microbiota–Derived Lysophospholipids to Restore Th17/Treg Homeostasis in Systemic Lupus Erythematosus
- Open Access
DDX21 Promotes Breast Cancer Growth and Metastasis via Stimulating RNAPII Elongation During Hypoxia
Hypoxia is a hallmark of solid tumors, and hypoxia‐inducible factors (HIFs) are the master transcription factors that allow cancer cells to sense and cope with a hypoxic microenvironment. However, the mechanism by which the HIF‐mediated transcription process is precisely regulated remains poorly understood. Here, we demonstrate that the RNA helicase DDX21 facilitates breast tumor growth and metastasis by triggering HIF‐mediated transcription elongation. Mechanistically, DDX21 induces the release of CDK9 from the 7SK complex, enhancing the interaction between CDK9 and HIF‐1α. This interaction stimulates the transcription elongation of HIF target genes by elevating the enrichment of phosphorylated RNA Polymerase II at serine 2 on the hypoxia‐response element of HIF target genes. These target genes, including IGFBP1, WNT1, WNT10B, TGFB1, PCK1, and SLC2A3, are critical for cancer cell proliferation and metastasis. Consequently, DDX21 enhances breast cancer cell proliferation, survival, migration, and invasion in vitro, and promotes breast tumor growth and metastasis in vivo. Importantly, DDX21 is highly expressed in breast tumors and correlates negatively with clinical outcomes in breast cancer patients. Our study reveals a novel mechanism of HIF regulation and positions DDX21 as a potential therapeutic target for disrupting the hypoxic adaptation machinery in breast cancer.
Open AccessDDX21 Promotes Breast Cancer Growth and Metastasis via Stimulating RNAPII Elongation During Hypoxia
Hypoxia is a hallmark of solid tumors, and hypoxia‐inducible factors (HIFs) are the master transcription factors that allow cancer cells to sense and cope with a hypoxic microenvironment. However, the mechanism by which the HIF‐mediated transcription process is precisely regulated remains poorly understood. Here, we demonstrate that the RNA helicase DDX21 facilitates breast tumor growth and metastasis by triggering HIF‐mediated transcription elongation. Mechanistically, DDX21 induces the release of CDK9 from the 7SK complex, enhancing the interaction between CDK9 and HIF‐1α. This interaction stimulates the transcription elongation of HIF target genes by elevating the enrichment of phosphorylated RNA Polymerase II at serine 2 on the hypoxia‐response element of HIF target genes. These target genes, including IGFBP1, WNT1, WNT10B, TGFB1, PCK1, and SLC2A3, are critical for cancer cell proliferation and metastasis. Consequently, DDX21 enhances breast cancer cell proliferation, survival, migration, and invasion in vitro, and promotes breast tumor growth and metastasis in vivo. Importantly, DDX21 is highly expressed in breast tumors and correlates negatively with clinical outcomes in breast cancer patients. Our study reveals a novel mechanism of HIF regulation and positions DDX21 as a potential therapeutic target for disrupting the hypoxic adaptation machinery in breast cancer.
- Open Access
- 8 April 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 12 (1)
Fecal virome transplantation attenuates arthritis in mice by remodeling gut ecology, systemic tryptophan metabolism, and innate immune responses
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic joint inflammation and systemic immune dysregulation. Emerging evidence suggests that the gut microbiome plays an important role in immune modulation in RA, yet the role of the gut virome remains poorly understood. Here, using the K/BxN serum-transfer arthritis model, we systematically evaluated the potential role of fecal virome transplantation (FVT) in modulating gut ecology and innate inflammatory responses. Arthritic mice exhibited marked alterations in gut virome composition compared with healthy controls. Administration of purified virus-like particles (VLPs) from healthy donors correlated with reductions in paw swelling, histopathological inflammation, bone erosion, circulating proinflammatory cytokines, and myeloid cell infiltration in inflamed tissues. In parallel, 16S rRNA sequencing showed that FVT remodeled the gut bacterial community toward a composition more similar to that of healthy controls. Targeted serum metabolomics revealed increased levels of microbiota-derived tryptophan metabolites, including indole-3-lactic acid and related indole derivatives, suggesting a link between gut microbial remodeling and systemic immunometabolic regulation. Collectively, these findings indicate that FVT may attenuate inflammatory arthritis by remodeling gut microbial ecology, potentially involving virome–bacteriome interactions and immunometabolic pathways.
- 8 April 2026
- Published by Springer Nature in npj Biofilms and Microbiomes
- Vol. 12 (1)
Open AccessFecal virome transplantation attenuates arthritis in mice by remodeling gut ecology, systemic tryptophan metabolism, and innate immune responses
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by chronic joint inflammation and systemic immune dysregulation. Emerging evidence suggests that the gut microbiome plays an important role in immune modulation in RA, yet the role of the gut virome remains poorly understood. Here, using the K/BxN serum-transfer arthritis model, we systematically evaluated the potential role of fecal virome transplantation (FVT) in modulating gut ecology and innate inflammatory responses. Arthritic mice exhibited marked alterations in gut virome composition compared with healthy controls. Administration of purified virus-like particles (VLPs) from healthy donors correlated with reductions in paw swelling, histopathological inflammation, bone erosion, circulating proinflammatory cytokines, and myeloid cell infiltration in inflamed tissues. In parallel, 16S rRNA sequencing showed that FVT remodeled the gut bacterial community toward a composition more similar to that of healthy controls. Targeted serum metabolomics revealed increased levels of microbiota-derived tryptophan metabolites, including indole-3-lactic acid and related indole derivatives, suggesting a link between gut microbial remodeling and systemic immunometabolic regulation. Collectively, these findings indicate that FVT may attenuate inflammatory arthritis by remodeling gut microbial ecology, potentially involving virome–bacteriome interactions and immunometabolic pathways.
- Open Access
- 28 May 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (6) , 965-976
Bifidobacterium animalis subsp. lactis modulates early‐life immune response and gut metabolism
Background: The maturation of the immune system is critical during early life, as it involves the differentiation, maturation, and establishment of immune tolerance of immune cells. This process is influenced not only by genetic factors but also by environmental factors, particularly the symbiotic microbiota. Bifidobacterium animalis subsp. lactis (BB‐12), originally found in dairy products, is widely used in infant formula and dietary supplements. However, its role and mechanisms in immune development during early life remain unclear. Methods: Using GF mice as the experimental model, B. animalis subsp. lactis BB‐12 was administered via gavage during early life. In the juvenile stage, changes in T‐cell subsets in the spleen, thymus, and gut intraepithelial lymphocytes (IEL) were assessed using spectral flow cytometry. Additionally, targeted metabolomics analysis of tryptophan metabolism and short‐chain fatty acid pathways in colonic tissue was conducted to explore how B. animalis subsp. lactis BB‐12 influences the immune system through gut microbiota metabolism. Results: BB‐12 effectively modulates the gut immune microenvironment, leading to beneficial changes in T‐cell subsets in key immune tissues such as the spleen, thymus, and gut IELs. Metabolomics analysis further supports these findings by showing that BB‐12 intervention greatly increased the production of tryptophan derivatives and acetic acid in the colon of GF mice. Conclusion: The findings provide theoretical evidence for the role of B. animalis subsp. lactis in immune system development and support its application in dietary supplements, suggesting potential as a component for infant immune health and in preventing immune‐related diseases.
- 28 May 2025
- Published by Wiley in Animal Models and Experimental Medicine
- Vol. 8 (6) , 965-976
Open AccessBifidobacterium animalis subsp. lactis modulates early‐life immune response and gut metabolism
Background: The maturation of the immune system is critical during early life, as it involves the differentiation, maturation, and establishment of immune tolerance of immune cells. This process is influenced not only by genetic factors but also by environmental factors, particularly the symbiotic microbiota. Bifidobacterium animalis subsp. lactis (BB‐12), originally found in dairy products, is widely used in infant formula and dietary supplements. However, its role and mechanisms in immune development during early life remain unclear. Methods: Using GF mice as the experimental model, B. animalis subsp. lactis BB‐12 was administered via gavage during early life. In the juvenile stage, changes in T‐cell subsets in the spleen, thymus, and gut intraepithelial lymphocytes (IEL) were assessed using spectral flow cytometry. Additionally, targeted metabolomics analysis of tryptophan metabolism and short‐chain fatty acid pathways in colonic tissue was conducted to explore how B. animalis subsp. lactis BB‐12 influences the immune system through gut microbiota metabolism. Results: BB‐12 effectively modulates the gut immune microenvironment, leading to beneficial changes in T‐cell subsets in key immune tissues such as the spleen, thymus, and gut IELs. Metabolomics analysis further supports these findings by showing that BB‐12 intervention greatly increased the production of tryptophan derivatives and acetic acid in the colon of GF mice. Conclusion: The findings provide theoretical evidence for the role of B. animalis subsp. lactis in immune system development and support its application in dietary supplements, suggesting potential as a component for infant immune health and in preventing immune‐related diseases.
- Open Access
- 23 December 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-22
HFD aggravated the arthritis and atherosclerosis by altering the intestinal status and gut microbiota
Rheumatoid arthritis (RA) and cardiovascular disease (CVD) are both the chronic inflammatory disease. To investigate the influence of secondary atherosclerosis on arthritis mice, we treated the ApoE−/− mice with K/BxN serum and high fat diet (HFD), and subsequently assessed the phenotypes as well as immune profiles of K/BxN serum and HFD induced ApoE−/− mice. We found that HFD treatment aggravated the hyperlipidemia, atherosclerotic lesions, ankle swelling and arthropathy of mice. We further demonstrated that HFD altered the gut microbiota and metabolism, intestinal homeostasis and Th17/Treg cell balance in lamina propria lymphocytes. Moreover, HFD decreased the number of Peyer’ s patches and altered the expression profiling of gut immune cells. In addition, HFD increased the number of aortic leukocytes and macrophages, then aggravated the atherosclerosis in aorta, which led to greater inflammation in mice aorta and aortic root. Collectively, our study indicated that HFD aggravated the arthritis and atherosclerosis, which may be contributed by microbiota dysbiosis, the intestinal permeability and disrupted immunological homeostasis.
- 23 December 2024
- Published by Springer Nature in Molecular Medicine
- Vol. 30 (1) , 1-22
Open AccessHFD aggravated the arthritis and atherosclerosis by altering the intestinal status and gut microbiota
Rheumatoid arthritis (RA) and cardiovascular disease (CVD) are both the chronic inflammatory disease. To investigate the influence of secondary atherosclerosis on arthritis mice, we treated the ApoE−/− mice with K/BxN serum and high fat diet (HFD), and subsequently assessed the phenotypes as well as immune profiles of K/BxN serum and HFD induced ApoE−/− mice. We found that HFD treatment aggravated the hyperlipidemia, atherosclerotic lesions, ankle swelling and arthropathy of mice. We further demonstrated that HFD altered the gut microbiota and metabolism, intestinal homeostasis and Th17/Treg cell balance in lamina propria lymphocytes. Moreover, HFD decreased the number of Peyer’ s patches and altered the expression profiling of gut immune cells. In addition, HFD increased the number of aortic leukocytes and macrophages, then aggravated the atherosclerosis in aorta, which led to greater inflammation in mice aorta and aortic root. Collectively, our study indicated that HFD aggravated the arthritis and atherosclerosis, which may be contributed by microbiota dysbiosis, the intestinal permeability and disrupted immunological homeostasis.
- Open Access
- 17 May 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (5) , 1017
Sodium Polyoxotungstate Inhibits the Replication of Influenza Virus by Blocking the Nuclear Import of vRNP
Both pandemic and seasonal influenza are major health concerns, causing significant mortality and morbidity. Current influenza drugs primarily target viral neuraminidase and RNA polymerase, which are prone to drug resistance. Polyoxometalates (POMs) are metal cation clusters bridged by oxide anions. They have exhibited potent anti-tumor, antiviral, and antibacterial effects. They have remarkable activity against various DNA and RNA viruses, including human immunodeficiency virus, herpes simplex virus, hepatitis B and C viruses, dengue virus, and influenza virus. In this study, we have identified sodium polyoxotungstate (POM-1) from an ion channel inhibitor library. In vitro, POM-1 has been demonstrated to have potent antiviral activity against H1N1, H3N2, and oseltamivir-resistant H1N1 strains. POM-1 can cause virion aggregation during adsorption, as well as endocytosis. However, the aggregation is reversible; it does not interfere with virus adsorption and endocytosis. Our results suggest that POM-1 exerts its antiviral activity by inhibiting the nuclear import of viral ribonucleoprotein (vRNP). This distinct mechanism of action, combined with its wide range of efficacy, positions POM-1 as a promising therapeutic candidate for influenza treatment and warrants further investigation.
- 17 May 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (5) , 1017
Open AccessSodium Polyoxotungstate Inhibits the Replication of Influenza Virus by Blocking the Nuclear Import of vRNP
Both pandemic and seasonal influenza are major health concerns, causing significant mortality and morbidity. Current influenza drugs primarily target viral neuraminidase and RNA polymerase, which are prone to drug resistance. Polyoxometalates (POMs) are metal cation clusters bridged by oxide anions. They have exhibited potent anti-tumor, antiviral, and antibacterial effects. They have remarkable activity against various DNA and RNA viruses, including human immunodeficiency virus, herpes simplex virus, hepatitis B and C viruses, dengue virus, and influenza virus. In this study, we have identified sodium polyoxotungstate (POM-1) from an ion channel inhibitor library. In vitro, POM-1 has been demonstrated to have potent antiviral activity against H1N1, H3N2, and oseltamivir-resistant H1N1 strains. POM-1 can cause virion aggregation during adsorption, as well as endocytosis. However, the aggregation is reversible; it does not interfere with virus adsorption and endocytosis. Our results suggest that POM-1 exerts its antiviral activity by inhibiting the nuclear import of viral ribonucleoprotein (vRNP). This distinct mechanism of action, combined with its wide range of efficacy, positions POM-1 as a promising therapeutic candidate for influenza treatment and warrants further investigation.
- Open Access
- 1 July 2022
- Published by Scientific Societies in Plant Disease
- Vol. 106 (7) , 1993
Boeremia exigua Causes Leaf Spot of Walnut Trees (Juglans regia) in China
- 1 July 2022
- Published by Scientific Societies in Plant Disease
- Vol. 106 (7) , 1993
Open AccessBoeremia exigua Causes Leaf Spot of Walnut Trees (Juglans regia) in China
- Open Access
- 1 June 2022
- Published by Scientific Societies in Plant Disease
- Vol. 106 (6) , 1754
Occurrence of Leaf Spot Caused by Mycocentrospora acerina on Japanese Ginseng (Panax japonicus) in China
- 1 June 2022
- Published by Scientific Societies in Plant Disease
- Vol. 106 (6) , 1754
Open AccessOccurrence of Leaf Spot Caused by Mycocentrospora acerina on Japanese Ginseng (Panax japonicus) in China
- Open Access
- 1 February 2021
- Published by Scientific Societies in Plant Disease
- Vol. 105 (2) , 488
First Report of Sclerotinia Blight Caused by Sclerotinia sclerotiorum on Pinellia ternata in China
Pinellia ternata is a perennial herb that belongs to the Araceae Family. The tuber of the P. ternata plant contains active ingredients such as alkaloids and pinellia starch, and can be used as a Ch...
- 1 February 2021
- Published by Scientific Societies in Plant Disease
- Vol. 105 (2) , 488
Open AccessFirst Report of Sclerotinia Blight Caused by Sclerotinia sclerotiorum on Pinellia ternata in China
Pinellia ternata is a perennial herb that belongs to the Araceae Family. The tuber of the P. ternata plant contains active ingredients such as alkaloids and pinellia starch, and can be used as a Ch...
- Open Access
- 1 August 2020
- Published by Scientific Societies in Plant Disease
- Vol. 104 (8) , 2291
Southern Blight Caused by Sclerotium rolfsii on Baiqian (Cynanchum stauntonii) in China
Cynanchum stauntonii (Decne.) Schltr. ex Levl. is a perennial medicinal herb (Family Asclepiadaceae) native to China and is widely distributed in many provinces including Hubei, Hunan, and Jiangsu....
- 1 August 2020
- Published by Scientific Societies in Plant Disease
- Vol. 104 (8) , 2291
Open AccessSouthern Blight Caused by Sclerotium rolfsii on Baiqian (Cynanchum stauntonii) in China
Cynanchum stauntonii (Decne.) Schltr. ex Levl. is a perennial medicinal herb (Family Asclepiadaceae) native to China and is widely distributed in many provinces including Hubei, Hunan, and Jiangsu....